Beta Drugs Q2 Results
- BSE: -
- NSE: BETA
- ISIN: INE351Y01019
- Sector: Biotechnology & Drugs
BSE
This stock is not traded on BSE
NSE
2,218.50
-40.40 (-1.79%)
-40.40 (-1.79%)Volume13.25 K
Updated: Fri 4 Sep, 2026 | 15:52:23
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Beta Drugs Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 86.32 | 102.53 | 2.48% | 113.85 | -41.36% |
| Depreciation/ Amortization | 4.24 | 4.35 | 13.79% | 5.44 | -25.73% |
| Operating Income | 17.07 | 23.02 | 6.81% | 27.42 | -48.43% |
| Net Income | 12.22 | 15.80 | 4.44% | 19.87 | -50.00% |
| Other Operating Expenses Total | 16.30 | 23.27 | 467.81% | 12.17 | -23.32% |
| Net Income Before Taxes | 16.44 | 22.04 | 5.09% | 26.58 | -49.83% |
| Total Revenue | 103.39 | 125.55 | 3.17% | 141.27 | -42.66% |
| Selling/ General/ Admin Expenses Total | 16.48 | 20.40 | 500.96% | 12.11 | 1.17% |
| Diluted Normalized EPS | 12.10 | 14.78 | -21.68% | 20.67 | -50.02% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.